Search - tctmd.com

Displaying 701 - 720 of 9941

Sort: Relevancy | Date

News Daily News

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

Michael O'Riordan

May 01, 2025

News Daily News

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Caitlin E. Cox

April 28, 2025

News Conference News CX Symposium 2025

Plant-Derived Compound Shows Early Promise for Small AAAs

L.A. McKeown

April 25, 2025

News Conference News HVS 2025

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

Yael L. Maxwell

April 21, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

Todd Neale

April 11, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Conference News EHRA 2025

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

Todd Neale

April 08, 2025

News Conference News ACC 2025

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

L.A. McKeown

April 07, 2025

Podcast Heart Valve Matters

Technology's Role in Treating Severe AS with Sammy Elmariah and David Playford

April 04, 2025

News Conference News ACC 2025

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Michael O'Riordan

April 04, 2025

News Conference News ACC 2025

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

L.A. McKeown

March 31, 2025

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

L.A. McKeown

March 30, 2025

News Conference News ACC 2025

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Yael L. Maxwell

March 30, 2025

News Conference News ACC 2025

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Caitlin E. Cox

March 30, 2025

News Conference News ACC 2025

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Michael O'Riordan

March 30, 2025

Presentation ACC 2025

Dapagliflozin after Transcatheter Aortic Valve Implantation

Presenter: Sergio Raposeiras-Roubin

March 29, 2025

News Features

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

Yael L. Maxwell

March 27, 2025

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Caitlin E. Cox

March 25, 2025

Advertisement

FDA Approves TAVI for Asymptomatic Patients With Severe Aortic Stenosis

TAVI and Complex/High-Risk PCI Safer if Staged, Registry Confirms

Plant-Derived Compound Shows Early Promise for Small AAAs

Solid Durability Seen With Surgical Resilia Tissue Aortic Valve

April 2025 Dispatch for the CV Team

COMPARE-TAVI 1: Myval Performs Well Against Sapien at 1 Year

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

Post-TAVI Pacemaker Tied to Poorer Long-term Outcomes

EARLY TAVR: Delaying Valve Replacement Increases Risk of Poor Outcomes

Technology's Role in Treating Severe AS with Sammy Elmariah and David Playford

DETECT-AS: Alert System Increases AV Replacement in Eligible Patients

Shelf-stable Product May Sub in for Frozen Plasma in Cardiac Surgery: FARES-II

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

More ALIGN-AR Data Bolster Potential for a Dedicated AR Device

Dapagliflozin Works Well for High-Risk TAVI Patients With HF: DapaTAVI

Strike Two: BHF PROTECT-TAVI Throws Cold Water on Embolic Protection

Dapagliflozin after Transcatheter Aortic Valve Implantation

What’s in a Name: Is It Time to Choose Between TAVI and TAVR?

What’s Going to Be Hot at ACC 2025?

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content